Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia
Meyer-Lindenberg, Andreas, Miletich, Robert S., Kohn, Philip D., Esposito, Giuseppe, Carson, Richard E., Quarantelli, Mario, Weinberger, Daniel R., Berman, Karen Faith·2002·Nature Neuroscience
DOI 10.1038/nn804
Cited by (646)
Items 101–200 of 646
- Role of dopamine D(2) receptors for antipsychotic activity.N. Ginovart, S. Kapur · 2012 · Handbook of Experimental Pharmacology
- α-Adrenoceptor modulation hypothesis of antipsychotic atypicalityT. Svensson · 2003 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
- TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophreniaTerry A. Hauser, Aaron J. Kucinski, Kristen Green-Jordan, G.J. Gatto, Scott R. Wersinger, Renae A. Hesse, Ewa K. Stachowiak, Michal K. Stachowiak, Roger L. Papke, P M Lippiello et al. · 2009 · Biochemical Pharmacology
- Developmental pathology, dopamine, and stress: a model for the age of onset of schizophrenia symptoms.Judy L. Thompson, M. Pogue-Geile, A. Grace · 2004 · Schizophrenia bulletin
- Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET StudyEuitae Kim, Oliver David Howes, Mattia Veronese, Katherine Beck, Seongho Seo, Jin Woo Park, Jae Sung Lee, Yun‐Sang Lee, Jun Soo Kwon · 2016 · Neuropsychopharmacology
- Catechol O-Methyltransferase (COMT) mRNA Expression in the Dorsolateral Prefrontal Cortex of Patients with SchizophreniaMitsuyuki Matsumoto, Cynthia Shannon Weickert, Senda Beltaifa, Bhaskar S. Kolachana, Jingshan Chen, Thomas M. Hyde, Mary M. Herman, Daniel R. Weinberger, Joel E. Kleinman · 2003 · Neuropsychopharmacology
- Altered probabilistic learning and response biases in schizophrenia: Behavioral evidence and neurocomputational modeling.Waltz, James A., Frank, Michael J., Wiecki, Thomas V., Gold, James M. · 2011 · Neuropsychology
- PET Studies of Cerebral Levodopa Metabolism: A Review of Clinical Findings and Modeling ApproachesYoshitaka Kumakura, Paul D. Cumming · 2009 · The Neuroscientist
- Dysregulation of Midbrain Dopamine System and the Pathophysiology of SchizophreniaSusan F. Sonnenschein, Felipe V. Gomes, Anthony A. Grace · 2020 · Frontiers in Psychiatry
- Role of basal ganglia neurocircuitry in the pathology of psychiatric disordersTom Macpherson, Takatoshi Hikida · 2019 · Psychiatry and Clinical Neurosciences
- Development, wiring and function of dopamine neuron subtypesGarritsen, Oxana, van Battum, Eljo Y., Grossouw, Laurens M., Pasterkamp, R. Jeroen · 2023 · Nature reviews. Neuroscience
- Impact of interacting functional variants in COMT on regional gray matter volume in human brainHonea, Robyn, Verchinski, Beth A., Pezawas, Lukas, Kolachana, Bhaskar S., Callicott, Joseph H., Mattay, Venkata S., Weinberger, Daniel R., Meyer-Lindenberg, Andreas · 2009 · NeuroImage
- Noninvasive remote activation of the ventral midbrain by transcranial direct current stimulation of prefrontal cortexVikram S. Chib, Kyongsik Yun, H Takahashi, Shinsuke Shimojo · 2013 · Translational Psychiatry
- Striatal Presynaptic Dopamine in Schizophrenia, Part I: Meta-Analysis of Dopamine Active Transporter (DAT) DensityPaolo Fusar‐Poli, Andreas Meyer‐Lindenberg · 2012 · Schizophrenia Bulletin
- Increased levels of midbrain immune-related transcripts in schizophrenia and in murine offspring after maternal immune activationTertia D. Purves-Tyson, Ulrike Weber‐Stadlbauer, Juliet Richetto, Debora A. Rothmond, Marie A. Labouesse, Marcello Polesel, Kate Robinson, Cynthia Shannon Weickert, Urs Meyer · 2019 · Molecular Psychiatry
- Measurement of Brain Regional α-[11C]Methyl-L-Tryptophan Trapping as a Measure of Serotonin Synthesis in Medication-FreePatients With Major DepressionPedro Rosa‐Neto, Mirko Dikšić, Hidehiko Okazawa, Marco Leyton, Nayyer Ghadirian, Shadreck Mzengeza, Akio Nakai, Guy Debonnel, Pierre Blier, Chawki Benkelfat · 2004 · Archives of General Psychiatry
- DRD2 polymorphisms modulate reward and emotion processing, dopamine neurotransmission and openness to experiencePeciña, Marta, Mickey, Brian J., Love, Tiffany, Wang, Heng, Langenecker, Scott A., Hodgkinson, Colin, Shen, Pei-Hong, Villafuerte, Sandra, Hsu, David, Weisenbach, Sara L. et al. · 2013 · Cortex
- The neural underpinnings of cognitive flexibility and their disruption in psychotic illnessWaltz, James A. · 2017 · Neuroscience
- The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic reviewT. Dahoun, Svenja V. Trossbach, N. Brandon, Carsten Korth, O. Howes · 2017 · Translational Psychiatry
- Mad genius revisited: Vulnerability to psychopathology, biobehavioral approach-avoidance, and creativity.Matthijs Baas, B. Nijstad, N. Boot, C. D. De Dreu · 2016 · Psychological bulletin
- Effects of High-Frequency Transcranial Magnetic Stimulation for Cognitive Deficit in Schizophrenia: A Meta-AnalysisYi Jiang, Zhiwei Guo, Guoqiang Xing, Lin He, Haitao Peng, Fei Du, Morgan A. McClure, Qiwen Mu · 2019 · Frontiers in Psychiatry
- Intramembrane receptor–receptor interactions: a novel principle in molecular medicineKjell Fuxé, Meritxell Canals, Maria Torvinen, Daniel J. Marcellino, Anton Terasmaa, Susanna Genedani, Giuseppina Leo, Diego Guidolin, Zaida Dı́az-Cabiale, Alicia Rivera et al. · 2006 · Journal of Neural Transmission
- Interindividual Differences in Functional Interactions among Prefrontal, Parietal and Parahippocampal Regions during Working MemoryMichael F. Glabus · 2003 · Cerebral Cortex
- Does dopamine mediate the psychosis-inducing effects of cannabis? A review and integration of findings across disciplinesKuepper, Rebecca, Morrison, Paul D., van Os, Jim, Murray, Robin M., Kenis, Gunter, Henquet, Cécile · 2010 · Schizophrenia Research
- The role of monoamine oxidase enzymes in the pathophysiology of neurological disordersDanielle N. Jones, Mary Ann Raghanti · 2021 · Journal of Chemical Neuroanatomy
- Clinical and positron emission tomography of Parkinson's disease caused by LRRK2Dena G. Hernandez, Coro Paisán‐Ruiz, Aideen M McInerney-Leo, Shushant Jain, Andreas Meyer‐Lindenberg, E. Whitney Evans, Karen Faith Berman, Janel O. Johnson, Georg W. J. Auburger, Alejandro A. Schäffer et al. · 2005 · Annals of Neurology
- Abnormal social behaviors in mice lacking Fgf17Kimberly A. Scearce-Levie, Erik D. Roberson, Hertzel C. Gerstein, Jeremy A. Cholfin, Vidya S Mandiyan, Nirao M. Shah, John L.R. Rubenstein, Lennart Mucke · 2007 · Genes Brain & Behavior
- Midbrain dopaminergic neurons: determination of their developmental fate by transcription factors.Horst H. Simon, Lavinia Bhatt, Daniel Gherbassi, Paola Sgadó, Lavinia Auber Alberi · 2003 · PubMed
- The effects of psychosocial stress on dopaminergic function and the acute stress responseBloomfield, Michael AP, McCutcheon, Robert A, Kempton, Matthew, Freeman, Tom P, Howes, Oliver · 2019 · eLife
- Increased Macrophages and C1qA, C3, C4 Transcripts in the Midbrain of People With SchizophreniaTertia D. Purves-Tyson, Kate Robinson, Amelia M. Brown, Danny Boerrigter, Helen Q. Cai, Christin Weissleder, Samantha J. Owens, Debora A. Rothmond, Cynthia Shannon Weickert · 2020 · Frontiers in Immunology
- Effects of Psychotic State and Task Demand on Prefrontal Function in Schizophrenia: An fMRI Study of Overt Verbal FluencyCynthia H.Y. Fu, John Suckling A, Steven Williams, Chris Andrew, Goparlen N. Vythelingum, Philip K. McGuire · 2005 · American Journal of Psychiatry
- Subchronic and chronic PCP treatment produces temporally distinct deficits in attentional set shifting and prepulse inhibition in ratsAlice Egerton, Lee Reid, Sandie McGregor, Susan M. Cochran, BRIAN J. MORRIS, Judith A. Pratt · 2008 · Psychopharmacology
- Oxytocin in schizophrenia: a review of evidence for its therapeutic effectsKai S. MacDonald, David Feifel · 2011 · Acta Neuropsychiatrica
- Subchronic Haloperidol Downregulates Dopamine Synthesis Capacity in the Brain of Schizophrenic Patients In VivoGerhard Gründer, Ingo Vernaleken, Matthias J. Müller, Eugen Davids, Nilufar Heydari, Hans‐Georg Buchholz, Peter Bartenstein, Ole Lajord Munk, Peter Stoeter, Dean Foster Wong et al. · 2002 · Neuropsychopharmacology
- Habit and Skill Learning in Schizophrenia: Evidence of Normal Striatal Processing With Abnormal Cortical InputThomas Wesley Weickert, Alejandro Terrazas, Llewellyn B. Bigelow, James D. Malley, Thomas M. Hyde, Michael F. Egan, Daniel R. Weinberger, Terry E. Goldberg · 2002 · Learning & Memory
- Striatal Response to Reward AnticipationOliver Grimm, Andreas Heinz, Henrik Walter, Peter Kirsch, Susanne Erk, Leila Haddad, Michael M. Plichta, Nina Romanczuk‐Seiferth, Lydia Pöhland, Sebastian Mohnke et al. · 2014 · JAMA Psychiatry
- Theranostic Biomarkers for SchizophreniaMatea Nikolac Perković, Gordana Nedić Erjavec, Dubravka Švob Štrac, S. Uzun, O. Kozumplik, N. Pivac · 2017 · International Journal of Molecular Sciences
- Functional Polymorphisms in PRODH Are Associated with Risk and Protection for Schizophrenia and Fronto-Striatal Structure and FunctionLucas Kempf, Kristin K. Nicodemus, Bhaskar S. Kolachana, Radhakrishna Vakkalanka, Beth A. Verchinski, Michael F. Egan, Richard E. Straub, Venkata Satyanand Mattay, Joseph H. Callicott, Daniel R. Weinberger et al. · 2008 · PLoS Genetics
- Distribution of mGluR1α and mGluR5 immunolabeling in primate prefrontal cortexE. Chris Muly, Marcelia Maddox, Yoland Smith · 2003 · The Journal of Comparative Neurology
- Dopamine Activates Noradrenergic Receptors in the Preoptic AreaCharlotte Anne Cornil, Jacques Balthazart, Patrick Motté, Laurent Massotte, Vincent Seutin · 2002 · Journal of Neuroscience
- Reproducing the dopamine pathophysiology of schizophrenia and approaches to ameliorate it: a translational imaging study with ketamineMichelle Kokkinou, Elaine E. Irvine, David R. Bonsall, Sridhar Natesan, Lisa A. Wells, Mark Smith, Justyna A. Glegola, Eleanor J. Paul, Kyoko Tossell, Mattia Veronese et al. · 2020 · Molecular Psychiatry
- Perinatal risks and childhood premorbid indicators of later psychosis: Next steps for early psychosocial interventionsLiu, Cindy H., Keshavan, Matcheri S., Tronick, Ed, Seidman, Larry J. · 2015 · Schizophrenia Bulletin
- Neuroimaging in Psychiatric DisordersJoseph C. Masdeu · 2011 · Neurotherapeutics
- Ventral striatal prediction error signaling is associated with dopamine synthesis capacity and fluid intelligenceFlorian Schlagenhauf, Michael A. Rapp, Quentin J. M. Huys, Anne Beck, Torsten Wüstenberg, Lorenz Deserno, Hans‐Georg Buchholz, Jan Kalbitzer, Ralph Buchert, Michael Bauer et al. · 2012 · Human Brain Mapping
- Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patientsChristine Esslinger, Susanne Englisch, Dragoš Inta, Franziska Rausch, Frederike N. Schirmbeck, Daniela U. Mier, Peter Kirsch, Andreas Meyer‐Lindenberg, Mathias Zink · 2012 · Schizophrenia Research
- Unique and shared roles of the posterior parietal and dorsolateral prefrontal cortex in cognitive functionsFumi Katsuki · 2012 · Frontiers in Integrative Neuroscience
- White matter tract abnormalities between rostral middle frontal gyrus, inferior frontal gyrus and striatum in first-episode schizophreniaQuan, Meina, Lee, Sang-Hyuk, Kubicki, Marek, Kikinis, Zora, Rathi, Yogesh, Seidman, Larry J., Mesholam-Gately, Raquelle I., Goldstein, Jill M., McCarley, Robert W., Shenton, Martha E. et al. · 2013 · Schizophrenia Research
- Genetically Determined Measures of Striatal D2 Signaling Predict Prefrontal Activity during Working Memory PerformanceAlessandro Bertolino, Paolo Taurisano, Nicola Marco Pisciotta, Giuseppe Blasi, Leonardo Fazio, Raffaella Romano, Barbara Gelao, Luciana Lo Bianco, Madia Lozupone, Annabella Di Giorgio et al. · 2010 · PLoS ONE
- Social Adversity in the Etiology of Psychosis: A Review of the EvidenceEleanor Longden, John Read · 2016 · American Journal of Psychotherapy
- Language disturbances in schizophrenia: the relation with antipsychotic medicationJanna N. de Boer, Alban Voppel, Sanne Brederoo, Frank N. K. Wijnen, Iris E. Sommer · 2020 · Schizophrenia
- The Dopamine System and the Pathophysiology of Schizophrenia: A Basic Science PerspectiveYukiori Goto, Anthony A. Grace · 2007 · International review of neurobiology
- Acetylcholine actions in the dorsomedial striatum support the flexible shifting of response patternsMichael E. Ragozzino · 2003 · Neurobiology of Learning and Memory
- Molecular substrates of schizophrenia: homeostatic signaling to connectivityMelissa A. Landek‐Salgado, Travis E. Faust, Akira Sawa · 2015 · Molecular Psychiatry
- N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: Relevance to schizophrenia and bipolar disorderOlivia May Dean, Maarten van den Buuse, Michael Berk, David Copolov, Christine Mavros, Ashley Ian Bush · 2011 · Neuroscience Letters
- The Wisconsin Card Sorting impairment in schizophrenia is evident in the first four trialsKristen J. Prentice, James M. Gold, Robert W. Buchanan · 2008 · Schizophrenia Research
- NMDA Receptor Internalization by Autoantibodies: A Reversible Mechanism Underlying Psychosis?Joseph C. Masdeu, Josep O. Dalmau, Karen Faith Berman · 2016 · Trends in Neurosciences
- Transcriptional regulation of mesencephalic dopaminergic neurons: The full circle of life and deathKambiz N. Alavian, Christian Scholz, Horst H. Simon · 2007 · Movement Disorders
- Clozapine increases both acetylcholine and dopamine release in rat ventral hippocampus: role of 5-HT1A receptor agonismYoung‐Chul Chung, Zhu Li, Jin Dai, Herbert Y. Meltzer, Junji Ichikawa · 2004 · Brain Research
- Midbrain Dopaminergic NeuronsHorst H. Simon, Lavinia Bhatt, Daniel Gherbassi, Paola Sgadó, Lavinia Auber Alberi · 2003 · Annals of the New York Academy of Sciences
- Epistasis between the DAT 3′ UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophreniaDiana Pinto Prata, Andrea Mechelli, Cynthia H.Y. Fu, Marco Picchioni, Timothea Toulopoulou, Elvira Bramon, Muriel Walshe, Robin M. Murray, David Andrew Collier, Philip K. McGuire · 2009 · Proceedings of the National Academy of Sciences
- Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.H. T. Mueller, V. Haroutunian, K. Davis, J. Meador-Woodruff · 2004 · Brain Research. Molecular Brain Research
- Transcranial direct current stimulation may modulate extinction memory in posttraumatic stress disorderMascha van ‘t Wout‐Frank, Sharon M. Longo, Madhavi K. Reddy, Noah S. Philip, Marguerite Bowker, Benjamin David Greenberg · 2017 · Brain and Behavior
- Behavioral and morphological alterations following neonatal excitotoxic lesions of the medial prefrontal cortex in ratsMiriam Schneider, Michael Koch · 2005 · Experimental Neurology
- Abnormal Striatal Dopamine Transmission in SchizophreniaJ. Brunelin, S. Fecteau, M. Suaud-Chagny · 2013 · Current Medicinal Chemistry
- Prevention and Schizophrenia--The Role of Dietary FactorsJohn Joseph McGrath, Amy Brown, David St Clair · 2010 · Schizophrenia Bulletin
- Biocompatible sulfur nitrogen co-doped carbon quantum dots for highly sensitive and selective detection of dopamineCunjin Wang, Huanxian Shi, Min Yang, Zhuoru Yao, Bin Zhang, Enzhou Liu, Xiaoyun Hu, Weiming Xue, Jun Fan · 2021 · Colloids and Surfaces B Biointerfaces
- Putative presynaptic dopamine dysregulation in schizophrenia is supported by molecular evidence from post-mortem human midbrainTertia D. Purves-Tyson, Samantha J. Owens, Debora A. Rothmond, Glenda Margaret Halliday, Kay L. Double, Julia Stevens, Toni McCrossin, Cynthia Shannon Weickert · 2017 · Translational Psychiatry
- Abnormalities in the dopamine system in schizophrenia may lie in altered levels of dopamine receptor-interacting proteinsJie Bai, Fang He, Svetlana I. Novikova, Ashiwel S. Undie, Stella M. Dracheva, Vahram H. Haroutunian, Michael S. Lidow · 2004 · Biological Psychiatry
- Neuregulin-1 and schizophrenia in the genome-wide association study eraMd Shaki Mostaid, David Lloyd, Benny Liberg, Suresh Sundram, Avril M. Pereira, Christos Pantelis, Tim Karl, Cynthia Shannon Weickert, Ian Everall, Chad Bousman · 2016 · Neuroscience & Biobehavioral Reviews
- A Critique of the Dopamine Hypothesis of Schizophrenia and PsychosisJoanna Moncrieff · 2009 · Harvard Review of Psychiatry
- Neural Correlates of Probabilistic Category Learning in Patients with SchizophreniaThomas Wesley Weickert, Terry E. Goldberg, Joseph H. Callicott, Qiang Chen, Jose A. Apud, Sumitra Das, Brad J. Zoltick, Michael F. Egan, Martijn Meeter, Catherine E. Myers et al. · 2009 · Journal of Neuroscience
- Dopamine, fronto-striato-thalamic circuits and risk for psychosisOrwa Dandash, Christos Pantelis, Alex Fornito · 2016 · Schizophrenia Research
- Does Therapeutic Repetitive Transcranial Magnetic Stimulation Cause Cognitive Enhancing Effects in Patients with Neuropsychiatric Conditions? A Systematic Review and Meta-Analysis of Randomised Controlled TrialsMartin, Donel M., McClintock, Shawn M., Forster, Jane, Loo, Colleen K. · 2016 · Neuropsychology Review
- Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: Analyses in patients and in perinatal Δ9-tetrahydrocannabinol-exposed ratsMartina Di Bartolomeo, Tibor Štark, Oriana Maria Maurel, Fabio Arturo Iannotti, Martin Kuchař, Jana Kučerová, Fabiana Piscitelli, Samuele Laudani, Vladimír Pekařík, Salvatore Salomone et al. · 2020 · Pharmacological Research
- Microvascular anomaly conditions in psychiatric disease. Schizophrenia – angiogenesis connectionPavel Katsel, Panos Roussos, Mikhail V. Pletnikov, Vahram H. Haroutunian · 2017 · Neuroscience & Biobehavioral Reviews
- Dopaminergic control of working memory and its relevance to schizophrenia: a circuit dynamics perspective.Shoji Tanaka · 2006 · Neuroscience
- Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerationsPim R.A. Heckman, Arjan Blokland, Eva Bollen, Jos Prickaerts · 2018 · Neuroscience & Biobehavioral Reviews
- The Role of Extrastriatal Dopamine D2 Receptors in SchizophreniaHidehiko Takahashi, Makoto Higuchi, Tetsuya Suhara · 2006 · Biological Psychiatry
- Remediation of attentional dysfunction in rats with lesions of the medial prefrontal cortex by intra-accumbens administration of the dopamine D2/3 receptor antagonist sulpirideMarie A. Pezze, Jeffrey W. Dalley, Trevor William Robbins · 2008 · Psychopharmacology
- Effects of Prefrontal Cortical Inactivation on Neural Activity in the Ventral Tegmental AreaYong Sang Jo, Jane Jean-Hee Lee, Sheri J. Y. Mizumori · 2013 · Journal of Neuroscience
- Schizophrenia: From the brain to peripheral markers. A consensus paper of the WFSBP task force on biological markersGerald Stoeber, Dorit Ben‐Shachar, Michal Cardon, Peter Falkai, Alfred Nji Fonteh, Micha Gawlik, Birte Yding Glenthoj, Edna Grünblatt, Assen V Jablensky, Yong‐Ku Kim et al. · 2009 · The World Journal of Biological Psychiatry
- Stereological studies of capillary length density in the frontal cortex of schizophrenicsPaweł Kreczmański, Rainald Schmidt‐Kastner, Helmut Heinsen, Harry W.M. Steinbusch, Patrick R. Hof, Christoph Schmitz · 2005 · Acta Neuropathologica
- Context-dependent cortical activation in response to financial reward and penalty: an event-related fMRI studyAkitsuki, Yuko, Sugiura, Motoaki, Watanabe, Jobu, Yamashita, Keiichi, Sassa, Yuko, Awata, Shuichi, Matsuoka, Hiroo, Maeda, Yasuhiro, Matsue, Yoshihiko, Fukuda, Hiroshi et al. · 2003 · NeuroImage
- A Systems Neuroscience Perspective of Schizophrenia and Bipolar DisorderSophia Frangou · 2014 · Schizophrenia Bulletin
- The relationship between immune and cognitive dysfunction in mood and psychotic disorder: a systematic review and a meta-analysisManuel Morrens, C. Overloop, Violette Coppens, Elke Loots, Minne Van Den Noortgate, S. Vandenameele, Marion Leboyer, Livia De Picker · 2022 · Molecular Psychiatry
- Positron Emission Tomography in Schizophrenia: A New PerspectiveN. Patel, N. S. Vyas, B. Puri, K. Nijran, A. Al-nahhas · 2010 · Journal of Nuclear Medicine
- Fibroblast growth factor receptor signaling affects development and function of dopamine neurons – inhibition results in a schizophrenia‐like syndrome in transgenic miceI. Klejbor, Jason M. Myers, K. Hausknecht, Thomas D. Corso, Angelo S. Gambino, J. Moryś, P. Maher, R. Hard, Jerry C. Richards, E. Stachowiak et al. · 2006 · Journal of Neurochemistry
- Asymmetry in dopamine D2/3 receptors of caudate nucleus is lost with ageIngo Vernaleken, Carsten Weibrich, Thomas Siessmeier, Hans‐Georg Buchholz, Frank Rösch, Andreas Heinz, Paul D. Cumming, Peter Stoeter, Peter Bartenstein, Gerhard Gründer · 2006 · NeuroImage
- Novel truncated isoform of SK3 potassium channel is a potent dominant-negative regulator of SK currents: implications in schizophreniaHiroaki Tomita, Vikram G. Shakkottai, George A. Gutman, Guoqiang Sun, William E. Bunney, Michael D. Cahalan, K. George Chandy, John Jay Gargus · 2003 · Molecular Psychiatry
- Maternal Immune Activation and the Development of Dopaminergic Neurotransmission of the Offspring: Relevance for Schizophrenia and Other PsychosesA. Aguilar-Valles, Brandon Rodrigue, E. Matta-Camacho · 2020 · Frontiers in Psychiatry
- Are genetic variants of COMT associated with addiction?Anne Tammimäki, Pekka T. Männistö · 2010 · Pharmacogenetics and Genomics
- The Neurocognitive Cost of Enhancing Cognition with Methylphenidate: Improved Distractor Resistance but Impaired UpdatingSean James Fallon, Marieke E. van der Schaaf, Niels ter Huurne, Roshan Cools · 2016 · Journal of Cognitive Neuroscience
- Transdiagnostic Prediction of Affective, Cognitive, and Social Function Through Brain Reward Anticipation in Schizophrenia, Bipolar Disorder, Major Depression, and Autism Spectrum DiagnosesKristina Schwarz, Carolin Moessnang, Janina Isabel Schweiger, Sarah Baumeister, Michael M. Plichta, Daniel Brandeis, Tobias Banaschewski, Carolin Wackerhagen, Susanne Erk, Henrik Walter et al. · 2019 · Schizophrenia Bulletin
- Opposite Effects of Catechol-O-Methyltransferase Val158Met on Cortical Function in Healthy Subjects and Patients with SchizophreniaDiana Pinto Prata, Andrea Mechelli, Cynthia H.Y. Fu, Marco Picchioni, Fergus Kane, Sridevi Kalidindi, Colm McDonald, Oliver David Howes, Eugenia Kravariti, Arsime Demjaha et al. · 2008 · Biological Psychiatry
- Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging.S. Bose, F. Turkheimer, O. Howes, M. Mehta, R. Cunliffe, Paul R. A. Stokes, P. Grasby · 2008 · Schizophrenia Research
- Presynaptic regulation of dopamine transmission in schizophrenia.G. Lyon, A. Abi-Dargham, Holly Moore, Jeffrey A. Lieberman, J. Javitch, David Sulzer · 2011 · Schizophrenia bulletin
- 3D‐Ridge Stocked Layers of Nitrogen‐Doped Mesoporous Carbon Nanosheets for Ultrasensitive Monitoring of Dopamine Released from PC12 Cells under K+ StimulationMohammed Y. Emran, Mohamed A. Shenashen, Hiromi Morita, Sherif A. El‐Safty · 2018 · Advanced Healthcare Materials
- The dopamine dysfunction in schizophrenia revisited: new insights into topography and course.R. Kuepper, M. Skinbjerg, A. Abi-Dargham · 2012 · Handbook of Experimental Pharmacology
- Complementary and Alternative Medicine (CAM)Marlene P. Freeman · 2009 · The Journal of Clinical Psychiatry
- Role of netrin-1 in the organization and function of the mesocorticolimbic dopamine systemCecilia Flores · 2011 · Journal of Psychiatry and Neuroscience